Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

NCT03896243 | Completed

• 1 other identifier: uterinarter
• Study Type: observational
• Target: 102
• Locations: 1 country
• Sites: 1

Brief Summary

Investigators would like to see the amh values after uterine artery ligation

Conditions

Uterine Artery Ligation; Ovarian Reserve

Keywords

Uterine atony; amh

Outcome Measures

Primary Outcomes (1)

• 1.ovarian reserve in patients with uterine artery ligation

  calculation of ovarian reserve with amh (ng/ml) after uterine artery ligation due to uterine atony

  12 months

Study Arms (2)

Uterine artery ligation (UAL)

We would like toinvite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Diagnostic Test: Uterine artery ligation (UAL)

Control Group:

We would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication. They would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Diagnostic Test: Uterine artery ligation (UAL)

Interventions

Uterine artery ligation (UAL) DIAGNOSTIC_TEST

Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Control Group:; Uterine artery ligation (UAL)

Eligibility Criteria

• Age: 18 Years - 35 Years
• Gender Eligibility Details: All participants are females undergoing delivery of their baby
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Patients who had uterine artery ligation during C-section. Control group is age-matched postpartum patients.

You may qualify if:

• age 18- 35 years
• no systemic or endocrine diseases
• patients who had uterine artery ligation due to atony
• healthy postpartum patients as controls

You may not qualify if:

• patients with PCOS
• Pregnancy with IVF or oosit donation
• Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc.
• Patients with BMI \>40

Sponsors & Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital: lead

Study Sites (1)

Pinar Yalcin Bahat

Istanbul, İ̇stanbul, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Uterine Inertia

Condition Hierarchy (Ancestors)

Dystocia; Obstetric Labor Complications; Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 27, 2019
• First Posted: March 29, 2019
• Study Start: January 1, 2018
• Primary Completion: January 1, 2019
• Study Completion: February 1, 2019
• Last Updated: March 29, 2019

Record last verified: 2019-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
• Time Frame: 12 months

Locations

TU (1)